No Data
No Data
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More
Alaunos Therapeutics | 10-Q: Q3 2024 Earnings Report
Express News | Shares in Alaunos Therapeutics Inc Hit Session Low With Volume Spike, Last Down 7.8% at $2
Precigen Terminates License Agreement With Alaunos Therapeutics
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
Express News | Alaunos Therapeutics : Co Provided Written Notice to Precigen to Terminate a&R License Agreement
Unlock the Full List